sign free newsletters brain plaque inhibitor developed merck tested larger studies efficacy unstoppable neurodegenerative disease monday pres barack obama proclaimed november national alzheimer disease awareness month administration ambitious goal prevent treat alzheimer 2025 currently approved therapies slow stop progression disease approaches showing promise study published today team merck research laboratories reports results early human animal trials drug called verubecestat targets production protein plaques associated disease summary discovery early stage profiling hope going new therapeutic alzheimer says team leader matthew kennedy represents decade investment project scientists definitive conclusions await results larger ongoing phase iii clinical trials assess efficacy effectiveness safety results